Cargando…

ADNP (Activity Dependent Neuroprotector Homeobox): A novel oncogene driving poor prognosis in high-grade serous carcinoma

Detalles Bibliográficos
Autor principal:	Turashvili, Gulisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940605/ https://www.ncbi.nlm.nih.gov/pubmed/31901854 http://dx.doi.org/10.1016/j.ebiom.2019.11.050

Ejemplares similares

Integrative proteogenomic analyses of human tumours identifies ADNP as a novel oncogenic mediator of cell cycle progression in high-grade serous ovarian cancer with poor prognosis
por: Karagoz, Kubra, et al.
Publicado: (2019)

Tumor BRCA Testing in High Grade Serous Carcinoma: Mutation Rates and Optimal Tissue Requirements
por: Turashvili, Gulisa, et al.
Publicado: (2020)

Are Columnar Cell Lesions the Earliest Non-Obligate Precursor in the Low-Grade Breast Neoplasia Pathway?
por: Strickland, Sarah, et al.
Publicado: (2022)

ADNP is associated with immune infiltration and radiosensitivity in hepatocellular carcinoma for predicting the prognosis
por: Wang, Xuan, et al.
Publicado: (2023)

Brain metastasis in advanced serous borderline tumor of the ovary: A case presentation()
por: Martin, Madhuri, et al.
Publicado: (2017)

Oncogenes in high grade serous adenocarcinoma of the ovary
por: Manasa, Pacharla, et al.
Publicado: (2020)

Lipid Droplet Accumulation Independently Predicts Poor Clinical Prognosis in High-Grade Serous Ovarian Carcinoma
por: Iwahashi, Naoyuki, et al.
Publicado: (2021)

Tumor Heterogeneity in Breast Cancer
por: Turashvili, Gulisa, et al.
Publicado: (2017)

Pathology of Hereditary Breast and Ovarian Cancer
por: Hodgson, Anjelica, et al.
Publicado: (2020)

What’s new in gynecologic pathology 2021: ovary and fallopian tube
por: Turashvili, Gulisa, et al.
Publicado: (2021)

Citicoline – a neuroprotector with proven effects on glaucomatous disease
por: Iulia, Chitu, et al.
Publicado: (2017)

Microbiota changes associated with ADNP deficiencies: rapid indicators for NAP (CP201) treatment of the ADNP syndrome and beyond
por: Kapitansky, Oxana, et al.
Publicado: (2020)

Neuropeptide GPCRs in neuroendocrinology: the case of activity-dependent neuroprotective protein (ADNP)
por: Gozes, Illana
Publicado: (2012)

Activity-dependent neuroprotective protein (ADNP): from autism to Alzheimer’s disease
por: Gozes, Illana
Publicado: (2015)

Activity-Dependent Neuroprotective Protein (ADNP): An Overview of Its Role in the Eye
por: Maugeri, Grazia, et al.
Publicado: (2022)

High level of homeobox A9 and PBX homeobox 3 expression in gastric cancer correlates with poor prognosis
por: Ma, Ying-Yu, et al.
Publicado: (2017)

Physiological Importance of Hydrogen Sulfide: Emerging Potent Neuroprotector and Neuromodulator
por: Panthi, Sandesh, et al.
Publicado: (2016)

Tyrosol as a Neuroprotector: Strong Effects of a “Weak” Antioxidant
por: Plotnikov, Mark B., et al.
Publicado: (2021)

Chalcone Derivatives with a High Potential as Multifunctional Antioxidant Neuroprotectors
por: Pérez-González, Adriana, et al.
Publicado: (2022)

Novel iodoquinazolinones bearing sulfonamide moiety as potential antioxidants and neuroprotectors
por: Soliman, Aiten M., et al.
Publicado: (2023)

Chromatin remodeler Activity-Dependent Neuroprotective Protein (ADNP) contributes to syndromic autism
por: D’Incal, Claudio Peter, et al.
Publicado: (2023)

ADNP Regulates Cognition: A Multitasking Protein
por: Gozes, Illana
Publicado: (2018)

Low Expression of RGS2 Promotes Poor Prognosis in High-Grade Serous Ovarian Cancer
por: Ihlow, Jana, et al.
Publicado: (2022)

Elafin drives poor outcome in high grade serous ovarian cancers and basal-like breast tumors
por: Labidi-Galy, S. Intidhar, et al.
Publicado: (2014)

Editorial: Hereditary Breast and Ovarian Cancer: Current Concepts of Prevention and Treatment
por: Grabenstetter, Anne, et al.
Publicado: (2020)

Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas
por: Wang, Aichun, et al.
Publicado: (2015)

Time is of the essence for ParaHox homeobox gene clustering
por: Garstang, Myles, et al.
Publicado: (2013)

High expression of ENPP1 in high-grade serous ovarian carcinoma predicts poor prognosis and as a molecular therapy target
por: Wang, Hanzhi, et al.
Publicado: (2021)

The poor prognosis of sarcomatoid carcinoma arising from low grade serous ovarian cancer: A case report and review of the literature
por: Haight, Paulina, et al.
Publicado: (2021)

Concurrent Primary Peritoneal Low-Grade Serous Carcinoma and Endometrial High-Grade Serous Carcinoma
por: Lockyer, Megan G., et al.
Publicado: (2015)

The Neuroprotector Benzothiazepine CGP37157 Extends Lifespan in C. elegans Worms
por: García-Casas, Paloma, et al.
Publicado: (2019)

High expression of Tie-2 predicts poor prognosis in primary high grade serous ovarian cancer
por: Sopo, Minna, et al.
Publicado: (2020)

Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer
por: Feng, Li-yuan, et al.
Publicado: (2021)

Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma
por: Kim, Se Ik, et al.
Publicado: (2020)

Multiomic characterization of high-grade serous ovarian carcinoma: editorial commentary on recent application and consideration for future directions
por: Jones, Tiffany Nicole, et al.
Publicado: (2023)

Homeobox oncogene activation by pan-cancer DNA hypermethylation
por: Su, Jianzhong, et al.
Publicado: (2018)

The ADNP Syndrome and CP201 (NAP) Potential and Hope
por: Gozes, Illana
Publicado: (2020)

High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma
por: Cui, Xuelian, et al.
Publicado: (2015)

MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis
por: Zanotti, Laura, et al.
Publicado: (2017)

The Effect of Neurotoxin MPTP and Neuroprotector Isatin on the Profile of Ubiquitinated Brain Mitochondrial Proteins
por: Buneeva, Olga, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_90endg26sg9srn82lqrk4ebj5r